|Podcasts|June 18, 2020

Introducing Pap Talk

Welcome to Pap Talk, a weekly medical podcast designed for doctors by doctors.

Each week, we will feature in-depth interviews, treatment advice, commentaries and cutting-edge research updates from some of the industry’s most respected practitioners.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!

Related Content

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2

ByLindsey Carr, Editor

December 22nd 2022

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1

ByLindsey Carr, Editor

December 21st 2022

Recap on reproductive rights with David Hackney, MD, MS

ByLindsey Carr, Editor

December 20th 2022

Pap Talk: Bonus episode S4E11: EMIGS with Dr. Nash Moawad

ByLindsey Carr, Editor,Morgan Ebert, Managing Editor

November 23rd 2022

Pap Talk S4E10: 2023 women's health outlook

ByLindsey Carr, Editor

November 22nd 2022

Latest CME

Multimedia

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

In-Person + Virtual Event

Cases and Conversations™: Redefining Treatment Pathways in Low-Grade Serous Ovarian Cancer

April 12, 2026

Multimedia

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Video

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Introducing Pap Talk

Newsletter

Related Content

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1

Recap on reproductive rights with David Hackney, MD, MS

Pap Talk: Bonus episode S4E11: EMIGS with Dr. Nash Moawad

Pap Talk S4E10: 2023 women's health outlook

Latest CME

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Cases and Conversations™: Redefining Treatment Pathways in Low-Grade Serous Ovarian Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Trending on Contemporary OB/GYN

FDA approves 5-year use for etonogestrel implant 68 mg contraceptive

Barbara Levy, MD: Patient-collected hrHPV testing is "huge" part of updated cervical cancer guideline

Barbara Levy, MD, reacts to HRSA's updated cervical cancer guidelines

Hypertensive pregnancies, optimized intervention, and long-term blood pressure, with Winok Lapidaire, PhD

RE104 30 mg demonstrates efficacy and safety in new phase 2 data for postpartum depression